An Indian Perspective on HIV-associated Lymphomas

Por Barta, Stefan K.
Publicado em 2013

New antibody approaches to lymphoma therapy

Por Suresh, Tejas, Lee, Lisa X, Joshi, Jitesh, Barta, Stefan K
Publicado em 2014

Linked-In: Design and Efficacy of Antibody Drug Conjugates in Oncology

Por Feld, Jonathan, Barta, Stefan K., Schinke, Carolina, Braunschweig, Ira, Zhou, Yiyu, Verma, Amit
Publicado em 2013

Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma

Por Barta, Stefan K, Lee, Jeannette Y, Sparano, Joseph A, Kaplan, Lawrence D, Noy, Ariela
Publicado em 2010

Pooled Analysis of Aids-Malignancy Consortium (AMC) Trials Evaluating Rituximab Plus either CHOP or Infusional EPOCH Chemotherapy in HIV-Associated Non-Hodgkin Lymphoma

Por Barta, Stefan K, Lee, Jeannette Y, Kaplan, Lawrence D, Noy, Ariela, Sparano, Joseph A
Publicado em 2011

Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanc...

Por Barta, Stefan K., Zou, Yiyu, Schindler, John, Shenoy, Niraj, Bhagat, Tushar D., Steidl, Ulrich, Verma, Amit
Publicado em 2012

Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma

Por Shastri, Aditi, Janakiram, Murali, Mantzaris, Ioannis, Yu, Yiting, Londono, Jaime S., Verma, Amit K., Barta, Stefan K.
Publicado no Oncotarget (2017)

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Por Ratner, L, Rauch, D, Abel, H, Caruso, B, Noy, A, Barta, S K, Parekh, S, Ramos, J C, Ambinder, R, Phillips, A, Harding, J, Baydoun, H H, Cheng, X, Jacobson, S
Publicado no Blood Cancer J (2016)

A Randomized Phase III Study in Low Grade Lymphoma Comparing Maintenance Anti-CD20 Antibody versus Observation following Induction Therapy: A trial of the ECOG-ACRIN Cancer Researc...

Por Barta, Stefan K., Li, Hailun, Hochster, Howard S., Hong, Fangxin, Weller, Edie, Gascoyne, Randy D., Habermann, Thomas M., Gordon, Leo I., Colocci, Natalia, Bengtson, Elizabeth M, Horning, Sandra J., Kahl, Brad S.
Publicado no Cancer (2016)

Mindfulness Based Stress Reduction (MBSR(BC)) in Breast Cancer: Evaluating Fear of Recurrence (FOR) as a Mediator of Psychological and Physical Symptoms in a Randomized Control Tri...

Por Lengacher, Cecile A., Shelton, Melissa M., Reich, Richard R., Barta, Michelle K., Johnson-Mallard, Versie, Moscoso, Manolete S., Paterson, Carly, Ramesar, Sophia, Budhrani, Pinky, Carranza, Irina, Lucas, Jean, Jacobsen, Paul B., Goodman, Matthew J., Kip, Kevin E.
Publicado em 2012

A new prognostic score for AIDS-related lymphomas in the rituximab-era

Por Barta, Stefan K., Xue, Xiaonan, Wang, Dan, Lee, Jeannette Y., Kaplan, Lawrence D., Ribera, Josep-Maria, Oriol, Albert, Spina, Michele, Tirelli, Umberto, Boue, Francois, Wilson, Wyndham H., Wyen, Christoph, Dunleavy, Kieron, Noy, Ariela, Sparano, Joseph A.
Publicado no Haematologica (2014)

Central nervous system involvement in AIDS-related lymphomas

Por Barta, Stefan K., Joshi, Jitesh, Mounier, Nicolas, Xue, Xiaonan, Wang, Dan, Ribera, Josep-Maria, Navarro, Jose-Tomas, Hoffmann, Christian, Dunleavy, Kieron, Little, Richard F., Wilson, Wyndham H., Spina, Michele, Galicier, Lionel, Noy, Ariela, Sparano, Joseph A.
Publicado no Br J Haematol (2016)

Baseline Immune Biomarkers as Predictors of MBSR(BC) Treatment Success in Off-Treatment Breast Cancer Patients

Por Reich, Richard R., Lengacher, Cecile A., Kip, Kevin E., Shivers, Steven C., Schell, Michael J., Shelton, Melissa M., Widen, Raymond H., Newton, Catherine, Barta, Michelle K., Paterson, Carly L., Farias, Jerrica R., Cox, Charles E., Klein, Thomas W.
Publicado no Biol Res Nurs (2014)

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)

Por Phillips, Adrienne, Fields, Paul, Hermine, Olivier, Taylor, Graham P, Delioukina, Maria, Horwitz, Steven, Ramos, Juan C, Meniane, Jean-Côme, Barta, Stefan K, Brites, Carlos, Pereria, Juliana, Beltran, Brady, Casanova, Luis, Wandroo, Farooq, Feldman, Tatyana, Dwyer, Karen, Kurman, Michael, Conlon, Kevin
Publicado no Retrovirology (2015)

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma

Por Barta, S. K., Samuel, M. S., Xue, X., Wang, D., Lee, J. Y., Mounier, N., Ribera, J.-M., Spina, M., Tirelli, U., Weiss, R., Galicier, L., Boue, F., Little, R. F., Dunleavy, K., Wilson, W. H., Wyen, C., Remick, S. C., Kaplan, L. D., Ratner, L., Noy, A., Sparano, J. A.
Publicado no Ann Oncol (2015)

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

Por Barta, Stefan K., Xue, Xiaonan, Wang, Dan, Tamari, Roni, Lee, Jeannette Y., Mounier, Nicolas, Kaplan, Lawrence D., Ribera, Josep-Maria, Spina, Michele, Tirelli, Umberto, Weiss, Rudolf, Galicier, Lionel, Boue, Francois, Wilson, Wyndham H., Wyen, Christoph, Oriol, Albert, Navarro, José-Tomás, Dunleavy, Kieron, Little, Richard F., Ratner, Lee, Garcia, Olga, Morgades, Mireia, Remick, Scot C., Noy, Ariela, Sparano, Joseph A.
Publicado em 2013

Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies

Por Costa, Luciano J., Maddocks, Kami, Epperla, Narendranath, Reddy, Nishitha M., Karmali, Reem, Umyarova, Elvira, Bachanova, Veronika, Costa, Cristiana, Glenn, Martha J., Chavez, Julio C., Calzada, Oscar, Lansigan, Frederick, Nasheed, Hossain, Barta, Stefan K., Zhou, Zheng, Jaglal, Michael, Chhabra, Saurabh, Hernandez-Ilizaliturri, Francisco, Xavier, Ana C., Mehta, Amitkumar, Peker, Deniz, Forero-Torres, Andreas, Al-Mansour, Zeina, Evens, Andrew M., Cohen, Jonathon B., Flowers, Christopher R., Fenske, Timothy S., Hamadani, Mehdi
Publicado no Am J Hematol (2017)